• Thurs news: Moderna targets $1.1B in R&D spending cuts. Gene therapy startup emerges. J&J leads $50M financing for imaging company. Sanofi gets into radioligands. GSK’s mRNA flu vax trial. See more on our front page

ema

  1. Pfenex receives FDA approval for PF708, alternative to Eli Lilly's Forteo

    Clinical-stage biotech company Pfenex gets FDA's approval for PF708. Pfenex is conducting a comparative study between PF708 and Eli Lilly's Forteo and will submit the final study report to FDA later this month.
    • anonymous
    • Thread
    • biotech drug eli lilly ema fda forteo fracture osteoporosis pf708 pfenex
    • Replies: 0
    • Forum: Eli Lilly
Top Bottom
Back